BioStem Technologies, Inc. (BSEM) stock
BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
BioStem Technologies total assets
Total assets on the balance sheet at the end of each period.
BioStem Technologies's total assets was $48.82M at Jun 30, 2026. For fiscal 2025 it was $50.03M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.03M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $48.82M | – |
| Q4 FY2025 | Dec 31, 2025 | $50.03M | – |
See a number that looks wrong?